Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Stein

Showing results (101-110 of 143) with videos related to

Pageof 15
Sort By:
Oncotarget|December 30, 2017
AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancerMelanie Kripp, Nicole Prasnikar, Ursula Vehling-Kaiser, et al.
Frontiers in Oncology|February 22, 2024
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trialAnna Brandt, Christoph Schultheiss, Konrad Klinghammer, et al.
Clinical Colorectal Cancer|July 13, 2024
Trifluridine/Tipiracil Based Chemoradiation in locally Advanced Rectal Cancer: The Phase I/II TARC TrialBenjamin Thiele, Alexander Stein, Christoph Schultheiß, et al.
Surgery|April 7, 2016
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysisMichael Tachezy, Florian Gebauer, Monika Janot, et al.
International Journal of Cancer|November 6, 2021
Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510Anica Högner, Salah-Eddin Al-Batran, Jens T Siveke, et al.
Cancer Treatment Reviews|May 14, 2021
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancerJean Bourhis, Alexander Stein, Jan Paul de Boer, et al.
JAMA Network Open|January 23, 2024
Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled TrialPeter Thuss-Patience, Anica Högner, Eray Goekkurt, et al.
Zeitschrift Fur Gastroenterologie|June 17, 2020
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations]Ulrike Attenberger, Claus Rödel, Michael Ghadimi, et al.
Oncotarget|June 11, 2015
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancerFriederike Braig, Manuela März, Aneta Schieferdecker, et al.
International Journal of Cancer|December 8, 2016
T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarkerNuray Akyüz, Anna Brandt, Alexander Stein, et al.
Pageof 15

Showing results (101-110 of 143) with videos related to

Sort By:
Pageof 15
Oncotarget|December 30, 2017
AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancerMelanie Kripp, Nicole Prasnikar, Ursula Vehling-Kaiser, et al.
Frontiers in Oncology|February 22, 2024
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trialAnna Brandt, Christoph Schultheiss, Konrad Klinghammer, et al.
Clinical Colorectal Cancer|July 13, 2024
Trifluridine/Tipiracil Based Chemoradiation in locally Advanced Rectal Cancer: The Phase I/II TARC TrialBenjamin Thiele, Alexander Stein, Christoph Schultheiß, et al.
Surgery|April 7, 2016
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysisMichael Tachezy, Florian Gebauer, Monika Janot, et al.
International Journal of Cancer|November 6, 2021
Pazopanib with 5-FU and oxaliplatin as first line therapy in advanced gastric cancer: A randomized phase-II study-The PaFLO trial. A study of the Arbeitsgemeinschaft Internistische Onkologie AIO-STO-0510Anica Högner, Salah-Eddin Al-Batran, Jens T Siveke, et al.
Cancer Treatment Reviews|May 14, 2021
Avelumab and cetuximab as a therapeutic combination: An overview of scientific rationale and current clinical trials in cancerJean Bourhis, Alexander Stein, Jan Paul de Boer, et al.
JAMA Network Open|January 23, 2024
Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled TrialPeter Thuss-Patience, Anica Högner, Eray Goekkurt, et al.
Zeitschrift Fur Gastroenterologie|June 17, 2020
[Prerequisites of magnetic resonance imaging for treatment planning in locally advanced rectal cancer - Interdisciplinary recommendations]Ulrike Attenberger, Claus Rödel, Michael Ghadimi, et al.
Oncotarget|June 11, 2015
Epidermal growth factor receptor mutation mediates cross-resistance to panitumumab and cetuximab in gastrointestinal cancerFriederike Braig, Manuela März, Aneta Schieferdecker, et al.
International Journal of Cancer|December 8, 2016
T-cell diversification reflects antigen selection in the blood of patients on immune checkpoint inhibition and may be exploited as liquid biopsy biomarkerNuray Akyüz, Anna Brandt, Alexander Stein, et al.
Pageof 15